Filter
498
Text search:
pharmacovigilance
Featured
53
142
Language
Document type
216
106
65
38
34
13
9
8
4
4
1
Countries / Regions
22
17
15
15
14
14
13
13
11
10
10
9
9
8
8
8
8
7
7
7
7
6
6
6
6
6
5
5
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
246
47
11
10
8
7
6
Toolboxes
68
56
49
38
37
24
14
5
5
3
3
3
2
2
1
1
1
1
1
Rreport of a WHO Consultative Meeting Kolkata India 2012
French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants
...
Programmatic update
April 2012
Executive Summary
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
DIAGNOSIS, MANAGEMENT OF UNCOMPLICATED AND SEVERE MALARIA
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
Master of Science in Pharmaceutical Management Dissertation
The manual is written for clinicians working at the district hospital (first-level referral care) who diagnose and manage sick adolescents and adults in resource constrained settings. It aims to support clinical reasoning, and to provide an effective clinical approach and protocols for the managemen
...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
